SEDAR-SEMICYUC consensus recommendations on the management of haemostasis disorders in severely ill patients with COVID-19 infection
Por:
Llau JV, Ferrandis R, Sierra P, Hidalgo F, Cassinello C, Gómez-Luque A, Quintana M, Amezaga R, Gero M, Serrano A and Marcos P
Publicada:
1 ago 2020
Ahead of Print:
23 may 2020
Resumen:
The infection by the coronavirus SARS-CoV-2, which causes the disease called COVID19, mainly causes alterations in the respiratory system. In severely ill patients, the disease oftenevolves into an acute respiratory distress syndrome that can predispose patients to a state ofhypercoagulability, with thrombosis at both venous and arterial levels. This predisposition presents a multifactorial physiopathology, related to hypoxia as well as to the severe inflammatoryprocess linked to this pathology, including the additional thrombotic factors present in many ofthe patients. In view of the need to optimise the management of hypercoagulability, the working groupsof the Scientific Societies of Anaesthesiology-Resuscitation and Pain Therapy (SEDAR) and ofIntensive, Critical Care Medicine and Coronary Units (SEMICYUC) have developed a consensus to establish guidelines for actions to be taken against alterations in haemostasis observedin severely ill patients with COVID-19. These recommendations include prophylaxis of venousthromboembolic disease in these patients, and in the peripartum, management of patients onlongterm antiplatelet or anticoagulant treatment, bleeding complications in the course of thedisease, and the interpretation of general alterations in haemostasis. (c) 2020 Published by Elsevier Espana, S.L.U. on behalf of Sociedad Espanola de Anestesiologia, Reanimacion y Terap ' eutica del Dolor.
Filiaciones:
:
Servicio de Anestesiología-Reanimación y Terapéutica del Dolor, Hospital Universitari Doctor Peset, SEDAR, Valencia, España
Ferrandis R:
Servicio de Anestesiología-Reanimación y Terapéutica del Dolor, Hospital Universitari i Politècnic La Fe, SEDAR, Valencia, España
Sierra P:
Servicio de Anestesiología-Reanimación y Terapéutica del Dolor, Fundació Puigvert, SEDAR , Barcelona, España
Hidalgo F:
Servicio de Anestesiología-Reanimación y Terapéutica del Dolor, Clínica Universidad de Navarra, SEDAR, Pamplona, Navarra, España
Cassinello C:
Servicio de Anestesiología-Reanimación y Terapéutica del Dolor, Hospital Universitario Miguel Servet, SEDAR, Zaragoza, España
Gómez-Luque A:
Servicio de Anestesiología-Reanimación y Terapéutica del Dolor, Hospital Universitario Virgen de la Victoria, SEDAR, Málaga, España
Quintana M:
Servicio de Medicina Intensiva, Hospital Universitario La Paz-Carlos III, SEMICYUC, Madrid, España
Amezaga R:
Servicio de Medicina Intensiva, Hospital Universitario Son Espases, SEMICYUC, Palma de Mallorca, Baleares, España
Gero M:
Servicio de Medicina Intensiva, Hospital Universitario, SEMICYUC, Burgos, España
Serrano A:
Servicio de Medicina Intensiva, Hospital Clínico Universitario, SEMICYUC, Valencia, España
Marcos P:
Servicio de Medicina Intensiva, Hospital Germans Trias i Pujol, SEMICYUC, Badalona, Barcelona, España
Green Published, Bronze
|